UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

CPT: pharmacometrics and systems pharmacology, 2017-02, Vol.6 (2), p.87-109

2017

Link zum Volltext

Verfügbarkeit prüfen

The Use of Model-Based Tumor-Size Metrics to Predict Survival

Clinical pharmacology and therapeutics, 2014-08, Vol.96 (2), p.133-135

2014

Link zum Volltext

Verfügbarkeit prüfen

Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it

Journal of antimicrobial chemotherapy, 2020-08, Vol.75 (8), p.2334-2343

2020

Link zum Volltext

Verfügbarkeit prüfen

Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial

Antimicrobial Agents and Chemotherapy, 2010-02, Vol.54 (2), p.614-619

2010

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetics and dosing simulations of amoxicillin in obese adults receiving co-amoxiclav

Journal of antimicrobial chemotherapy, 2020-12, Vol.75 (12), p.3611-3618

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients

Clinical pharmacology and therapeutics, 2012-11, Vol.92 (5), p.575-583

2012

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia

European journal of clinical pharmacology, 2015-01, Vol.71 (1), p.75-83

2015

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetic modeling of sustained release lithium in the serum, erythrocytes and urine of patients with bipolar disorder

European journal of clinical pharmacology, 2019-04, Vol.75 (4), p.519-528

2019

Link zum Volltext

Verfügbarkeit prüfen

Lewis Sheiner ISoP/UCSF Lecturer Award: From Drug Use to Statistical Models and Vice Versa

CPT: pharmacometrics and systems pharmacology, 2014-12, Vol.3 (12), p.1-4

Mentré, F

2014

Link zum Volltext

Verfügbarkeit prüfen

The Emergence of Linezolid Resistance among Enterococci in Intestinal Microbiota of Treated Patients Is Unrelated to Individual Pharmacokinetic Characteristics

Antimicrobial agents and chemotherapy, 2014-05, Vol.58 (5), p.2681-2687

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling

Clinical pharmacology and therapeutics, 2012-02, Vol.91 (2), p.234-242

2012

Link zum Volltext

Verfügbarkeit prüfen

Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia

Journal of antimicrobial chemotherapy, 2015-05, Vol.70 (5), p.1487-1494

2015

Link zum Volltext

Verfügbarkeit prüfen

Joint Population Pharmacokinetic Analysis of Zidovudine, Lamivudine, and Their Active Intracellular Metabolites in HIV Patients

Antimicrobial Agents and Chemotherapy, 2011-07, Vol.55 (7), p.3423-3431

2011

Link zum Volltext

Verfügbarkeit prüfen

The ISoP Standards and Best Practices Committee

Clinical pharmacology and therapeutics, 2014-06, Vol.95 (6), p.581-582

2014

Link zum Volltext

Verfügbarkeit prüfen

Overview of model‐building strategies in population PK/PD analyses: 2002–2004 literature survey

British journal of clinical pharmacology, 2007-11, Vol.64 (5), p.603-612

2007

Link zum Volltext

Verfügbarkeit prüfen

A Pharmacokinetic-Viral Kinetic Model Describes the Effect of Alisporivir as Monotherapy or in Combination With Peg-IFN on Hepatitis C Virologic Response

Clinical pharmacology and therapeutics, 2014-11, Vol.96 (5), p.599-608

2014

Link zum Volltext

Verfügbarkeit prüfen

Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members

CPT: pharmacometrics and systems pharmacology, 2013-06, Vol.2 (6), p.1-2

2013

Link zum Volltext

Verfügbarkeit prüfen

Powers of the Likelihood Ratio Test and the Correlation Test Using Empirical Bayes Estimates for Various Shrinkages in Population Pharmacokinetics

CPT: pharmacometrics and systems pharmacology, 2014-04, Vol.3 (4), p.1-9

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and Pharmacodynamic Variability of Fluindione in Octogenarians

Clinical pharmacology and therapeutics, 2012-05, Vol.91 (5), p.777-786

2012

Link zum Volltext

Verfügbarkeit prüfen

Best Practices in Population Modeling Should Always Be Evolving

CPT: pharmacometrics and systems pharmacology, 2013-07, Vol.2 (7), p.1-2

2013

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records

Antimicrobial agents and chemotherapy, 2023-05, Vol.67 (5), p.e0233918-e0233918

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development

CPT: pharmacometrics and systems pharmacology, 2015-06, Vol.4 (6), p.316-319

2015

Link zum Volltext

Verfügbarkeit prüfen

Influence of a priori Information, Designs, and Undetectable Data on Individual Parameters Estimation and Prediction of Hepatitis C Treatment Outcome

CPT: pharmacometrics and systems pharmacology, 2013-07, Vol.2 (7), p.1-9

2013

Link zum Volltext

Verfügbarkeit prüfen

A Model‐Based Illustrative Exploratory Approach to Optimize the Dosing of Peg‐IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy

CPT: pharmacometrics and systems pharmacology, 2015-01, Vol.4 (1), p.37-40

2015

Link zum Volltext

Verfügbarkeit prüfen

Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15

Journal of antimicrobial chemotherapy, 2015-05, Vol.70 (5), p.1466-1472

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 77

Suche als RSS-Feed

Aktive Filter

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(77)

Sprache

Englisch
(77)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

The Use of Model-Based Tumor-Size Metrics to Predict Survival

Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it

Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial

Population pharmacokinetics and dosing simulations of amoxicillin in obese adults receiving co-amoxiclav

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients

Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia

Population pharmacokinetic modeling of sustained release lithium in the serum, erythrocytes and urine of patients with bipolar disorder

Lewis Sheiner ISoP/UCSF Lecturer Award: From Drug Use to Statistical Models and Vice Versa

The Emergence of Linezolid Resistance among Enterococci in Intestinal Microbiota of Treated Patients Is Unrelated to Individual Pharmacokinetic Characteristics

Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling

Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia

Joint Population Pharmacokinetic Analysis of Zidovudine, Lamivudine, and Their Active Intracellular Metabolites in HIV Patients

The ISoP Standards and Best Practices Committee

Overview of model‐building strategies in population PK/PD analyses: 2002–2004 literature survey

A Pharmacokinetic-Viral Kinetic Model Describes the Effect of Alisporivir as Monotherapy or in Combination With Peg-IFN on Hepatitis C Virologic Response

Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members

Powers of the Likelihood Ratio Test and the Correlation Test Using Empirical Bayes Estimates for Various Shrinkages in Population Pharmacokinetics

Pharmacokinetic and Pharmacodynamic Variability of Fluindione in Octogenarians

Best Practices in Population Modeling Should Always Be Evolving

Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development

Influence of a priori Information, Designs, and Undetectable Data on Individual Parameters Estimation and Prediction of Hepatitis C Treatment Outcome

A Model‐Based Illustrative Exploratory Approach to Optimize the Dosing of Peg‐IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy

Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15

Aktive Filter

Suchergebnisse filtern